The END Fund, a private philanthropic initiative, works to eliminate the most common neglected infectious diseases in the world by 2030. To achieve that goal, it not only offers treatment to those who need it but also collaborates with other organizations working to eliminate those diseases. The alliance between The END Fund and the Pan American Health Organization (PAHO) is focused on supporting Guyana in eliminating lymphatic filariasis.
Founded in 2012, the END Fund has raised over $118 million to treat more than 140 million people around the world who are affected by neglected infectious diseases. The fund has also trained more than 900,000 healthcare workers and provided 10,000 surgeries to people with trachoma and lymphatic filariasis.
In 2006, the Legatum Foundation, a founding investor in The END Fund, helped finance programs to eliminate neglected infectious diseases in Rwanda and Burundi. In four years, the programs treated more than 8 million people for diseases such as soil-transmitted helminths (roundworms), schistosomiasis and lymphatic filariasis. The low-cost interventions demonstrated the feasibility of rapidly expanding programs nationwide to treat these diseases and prompted the creation of The END Fund as a philanthropic platform to engage other partners in eliminating this type of disease.
The END Fund works with governments, non-governmental organizations, pharmaceutical partners, and academics to manage high-impact strategic investments that seek to improve health systems and services that serve affected communities and help to eliminate these diseases.